Revolution Medicines, Inc 10-Q for FY2022 Q1
Revolution Medicines, Inc. (RVMD)
10-Q
2022-05-09
For: 2022-03-31
View Original
Added on
April 10, 2026
About this 10-Q
Revolution Medicines, Inc filed this 10-Q on May 9, 2022, covering the quarter ended March 31, 2022 (FY2022 Q1).
Headline figures
Quarter ended March 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $7.58M
- down 25.2% from $10.13M a year earlier
- Net loss
- $57.65M
- compared with a net loss of $37.18M a year earlier